Cigna Group financial data

Symbol
CI on NYSE
Location
Bloomfield, CT
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 81% % -3.8%
Quick Ratio 11% % 10%
Debt-to-equity 277% % 0.53%
Operating Margin 3.4% % -12%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 263,528,277 shares -3.7%
Common Stock, Shares, Outstanding 263,464,000 shares -3.8%
Entity Public Float $88,000,000,000 USD -4.5%
Common Stock, Value, Issued $4,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Diluted 268,563,000 shares -5.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $274,900,000,000 USD 11%
Operating Income (Loss) $9,200,000,000 USD -2.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $7,781,000,000 USD 48%
Income Tax Expense (Benefit) $1,493,000,000 USD 0.13%
Earnings Per Share, Basic 22.33 USD/shares 82%
Earnings Per Share, Diluted 22.18 USD/shares 83%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $7,676,000,000 USD 1.7%
Inventory, Net $7,338,000,000 USD 9.7%
Other Assets, Current $2,976,000,000 USD 8.9%
Assets, Current $47,814,000,000 USD -2.2%
Other Long-term Investments $5,037,000,000 USD
Property, Plant and Equipment, Net $3,651,000,000 USD
Intangible Assets, Net (Excluding Goodwill) $28,560,000,000 USD -2.9%
Goodwill $44,924,000,000 USD 1.2%
Other Assets, Noncurrent $2,885,000,000 USD 3.6%
Assets $157,919,000,000 USD 1.3%
Accounts Payable, Current $10,659,000,000 USD 15%
Liabilities, Current $56,342,000,000 USD -2.8%
Long-term Debt and Lease Obligation $30,871,000,000 USD 6.7%
Deferred Income Tax Liabilities, Net $7,145,000,000 USD 2.4%
Other Liabilities, Noncurrent $4,238,000,000 USD 32%
Liabilities $116,045,000,000 USD 1.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,806,000,000 USD -20%
Retained Earnings (Accumulated Deficit) $47,865,000,000 USD 10%
Stockholders' Equity Attributable to Parent $41,713,000,000 USD 1.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $41,874,000,000 USD 1.5%
Liabilities and Equity $157,919,000,000 USD 1.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,920,000,000 USD -60%
Net Cash Provided by (Used in) Financing Activities $3,681,000,000 USD -46%
Net Cash Provided by (Used in) Investing Activities $1,197,000,000 USD
Common Stock, Shares Authorized 600,000,000 shares 0%
Common Stock, Shares, Issued 404,600,000 shares 0.52%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $555,000,000 USD -131%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7,736,000,000 USD 1.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities $379,000,000 USD 13%
Deferred Tax Assets, Valuation Allowance $2,374,000,000 USD
Deferred Tax Assets, Gross $3,848,000,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $5,492,000,000 USD 86%
Property, Plant and Equipment, Gross $13,753,000,000 USD
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $1,538,000,000 USD 4.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $1,743,000,000 USD 2.3%
Depreciation, Depletion and Amortization $2,775,000,000 USD 0%
Deferred Tax Assets, Net of Valuation Allowance $1,474,000,000 USD
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%